NAS:XDNA

Kelly CRISPR & Gene Editing Technology ETF

$ 7.38 0 ( +0%) 11:51 AM EST
PE Ratio:
25.51
PB Ratio:
2.4
Volume:
-
Dividend Yield %:
0
Last Holding update 2024-01-24 23 Stocks (0 new)
Value $3.00 Mil Turnover 17 %
Top Holdings: CRSP(14.76%) BEAM(13.41%) TMO(9.97%) NTLA(8.76%) PRME(6.07%)
Portfolio Report
Registrant: Kelly CRISPR & Gene Editing Technology ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Key Statistics

Name Value
Day's Open ($) 7.38
Day's Range ($) 7.38 - 7.38
Day's Volume
52-Week Range ($) 5.87 - 9.38
Beta -
Volatility -
14-Day RSI 53.45
14-Day ATR ($) 0.155477
20-Day SMA ($) 7.3845

Fundamental Data

Name Value
Market Cap (Mil $) 2.583
Shares Outstanding (Mil) -
PE Ratio 25.51
PE Ratio (10y Range) 18.6 - 25.51
PE Ratio (10y Median) 25.51
PB Ratio 2.4
PB Ratio (10y Range) 2.21 - 3.08
PB Ratio (10y Median) 2.4

Dividend Data

Name Value
Dividends per Share (TTM) ($) -
Dividend Yield % -
Dividend Yield % (10y Range) 0.08 - 0.16
Dividend Yield % (10y Median) 0.1
Next Dividend Payment Date
Dividend Frequency -

XDNA Kelly CRISPR & Gene Editing Technology ETF Fundamental Charts

Historical TTM Price-to-Earnings for XDNA Kelly CRISPR & Gene Editing Technology ETF

Historical TTM Price-to-Earnings without NRI for XDNA Kelly CRISPR & Gene Editing Technology ETF

Historical Price-to-Book Ratio for XDNA Kelly CRISPR & Gene Editing Technology ETF

Historical Dividend Yields for XDNA Kelly CRISPR & Gene Editing Technology ETF

XDNA Kelly CRISPR & Gene Editing Technology ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with NAS:XDNA

No Available Data

NAS:XDNA is held by these investors

No Available Data
Kelly CRISPR & Gene Editing Te... Top Holdings of 2023-11-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
CRSP 		CRISPR Therapeutics AG
5,698
380.230
+35.28%
14.760
+3.85%
0.010
-0.26%
-20.88%
4208.157
Biotechnology
BEAM 		Beam Therapeutics Inc
12,306
345.550
+45.87%
13.410
+4.22%
0.020
-5.95%
-11.52%
1982.917
Biotechnology
TMO 		Thermo Fisher Scientific Inc
518
256.800
-1.89%
9.970
-0.23%
0.000
-6.30%
+5.71%
214223.099
Medical Diagnostics & Research
NTLA 		Intellia Therapeutics Inc
7,616
225.660
+5.43%
8.760
+0.45%
0.010
-32.56%
-50.61%
1526.736
Biotechnology
PRME 		Prime Medicine Inc
21,546
156.420
+144.29%
6.070
+3.59%
0.020
-8.04%
-53.30%
484.322
Biotechnology
EDIT 		Editas Medicine Inc
14,406
151.700
+9.24%
5.890
+0.50%
0.020
-33.19%
-68.81%
255.073
Biotechnology
CRBU 		Caribou Biosciences Inc
21,784
127.870
-20.62%
4.960
-1.37%
0.020
+29.67%
-55.76%
229.971
Biotechnology
VERV 		Verve Therapeutics Inc
9,968
112.440
+27.40%
4.360
+0.94%
0.010
+8.38%
-53.59%
543.710
Biotechnology
PSTX 		Poseida Therapeutics Inc
41,412
110.570
-22.38%
4.290
-1.02%
0.040
-15.89%
-24.40%
245.263
Biotechnology
ABBV 		AbbVie Inc
728
103.660
-9.45%
4.020
-0.46%
0.000
+10.19%
+34.81%
355893.226
Drug Manufacturers

Kelly CRISPR & Gene Editing Technology ETF's Historical Top Holdings Breakdowns

Kelly CRISPR & Gene Editing Technology ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
BEAM 		Beam Therapeutics Inc2023-11-30Add
+4.22%
●
17.69 ($23.62) 30.76
$24.06
1.86%
Add 45.87%
12,306
3,870
CRSP 		CRISPR Therapeutics AG2023-11-30Add
+3.85%
●
38.62 ($49.87) 72.18
$49.41
-0.92%
Add 35.28%
5,698
1,486
PRME 		Prime Medicine Inc2023-11-30Add
+3.59%
●
5.59 ($8.68) 13.24
$4.04
-53.51%
Add 144.29%
21,546
12,726
DTIL 		Precision BioSciences Inc2023-11-30Reduce
-1.57%
●
8.58 ($11.01) 14.1
$8.42
-23.52%
Reduce -56.92%
2,087
-82,812
XPAR:SAN 		Sanofi SA2023-11-30Add
+1.47%
●
81.44 (€95.27) 103.98
€97.70
2.55%
Add 80.56%
910
406
CRBU 		Caribou Biosciences Inc2023-11-30Reduce
-1.37%
●
3.58 ($4.82) 6.39
$2.54
-47.20%
Reduce -20.62%
21,784
-5,660
TSVT 		2seventy bio Inc2023-11-30Add
+1.04%
●
1.57 ($3.3) 5.19
$4.72
43.03%
Add 143.54%
24,724
14,572
PSTX 		Poseida Therapeutics Inc2023-11-30Reduce
-1.02%
●
1.83 ($2.26) 2.85
$2.52
11.73%
Reduce -22.38%
41,412
-11,940
VERV 		Verve Therapeutics Inc2023-11-30Add
+0.94%
●
8.84 ($12.21) 18.7
$6.42
-47.38%
Add 27.4%
9,968
2,144
ALLO 		Allogene Therapeutics Inc2023-11-30Add
+0.91%
●
2.28 ($3.18) 4.19
$2.92
-8.33%
Add 43.07%
32,998
9,934

Kelly CRISPR & Gene Editing Technology ETF Total Holding History ($B)

To

Kelly CRISPR & Gene Editing Technology ETF's Asset Allocation

To

Kelly CRISPR & Gene Editing Technology ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Kelly CRISPR & Gene Editing Technology ETF's Hypothetical Growth since 2023-11-30

Kelly CRISPR & Gene Editing Technology ETF's Yearly Returns

Year Portfolio % % Excess Gain %

Kelly CRISPR & Gene Editing Technology ETF's Holdings Heat Map

Size field:

Kelly CRISPR & Gene Editing Technology ETF's Holdings Bubble Chart

Kelly CRISPR & Gene Editing Technology ETF News

  • 1

Discussions on Kelly CRISPR & Gene Editing Technology ETF

User's Avatar
How would you rate this stock? XDNA
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.